Loading...
•
Jul 31, 2020
HealthEquity Q2 2021 Earnings Report
Reported strong second quarter results, driven by revenue growth and increased synergy target.
Key Takeaways
HealthEquity reported a strong second quarter with a 103% increase in revenue to $176.0 million. The company achieved $60.0 million in adjusted EBITDA and sequential growth in HSA assets by over $700 million. They also raised their net synergy target to $80 million.
Revenue increased by 103% to $176.0 million compared to the previous year.
Net loss was $0.1 million, while non-GAAP net income reached $30.1 million.
Adjusted EBITDA increased by 48% to $60.0 million.
Total HSAs grew to 5.4 million, a 29% increase year-over-year.
Revenue by Segment
Forward Guidance
For the fiscal year ending January 31, 2021, management expects revenues of $720 million to $730 million. Its outlook is for net loss between $13 million and $5 million, resulting in net loss per diluted share of $0.17 to $0.08. Its outlook for non-GAAP net income is between $111 million and $119 million, resulting in non-GAAP net income per diluted share of $1.48 to $1.58. Management expects Adjusted EBITDA of $226 million to $236 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...